首页 | 本学科首页   官方微博 | 高级检索  
   检索      

用聚类法分析受抗真菌物质处理后的酵母细胞全基因表达谱
引用本文:张亮,张岩,周一鸣,安爽,果德安,周玉祥,曾令文,程京.用聚类法分析受抗真菌物质处理后的酵母细胞全基因表达谱[J].生物化学与生物物理进展,2002,29(4):538-542.
作者姓名:张亮  张岩  周一鸣  安爽  果德安  周玉祥  曾令文  程京
作者单位:1. 清华大学生物科学与技术系,北京,100084;生物芯片北京国家工程研究中心,北京,100084
2. 生物芯片北京国家工程研究中心,北京,100084
3. 北京大学天然药物及仿生药物国家重点实验室,北京,100083
4. 清华大学生物科学与技术系,北京,100084;清华大学生物膜与膜工程国家重点实验室,北京,100084;生物芯片北京国家工程研究中心,北京,100084
5. 清华大学生物科学与技术系,北京,100084;清华大学生物膜与膜工程国家重点实验室,北京,100084;生物芯片北京国家工程研究中心,北京,100084;清华大学医学院药理系,北京,100084
基金项目:国家自然科学基金(39889001, 39825108, 30070917)及国家重点基础研究(G19990116)资助项目.
摘    要:微阵列DNA芯片技术可以并行分析成千上万个基因的表达情况,它为研究药物的作用机制提供了一个新的高效技术平台.用9种已知和未知作用机理的抗真菌化合物处理酵母细胞,并得到酵母细胞的全基因表达谱,然后对其进行聚类分析.结果表明作用机制类似的化合物具有相近的聚类关系.两性霉素B和制霉菌素、酮康唑和克霉唑都是已知的作用机制类似的抗真菌药物.通过对基因表达谱进行聚类分析,发现前一组和后一组分别被聚类在一起.另外已知澳洲茄胺抑制的是细胞膜上麦角固醇的合成,聚类分析表明它与酮康唑,克霉唑的聚类很靠近.对微阵列DNA芯片产生的基因表达谱进行聚类分析,由于作用机制相似的药物会被聚类在一起,因此根据未知药物和已知药物的聚类关系,可以了解未知药物的作用机制,这对于加速新药开发的步伐具有十分重要的意义.

关 键 词:微阵列DNA芯片,抗真菌药物,聚类分析
收稿时间:2002/1/25 0:00:00
修稿时间:2002年1月25日

Cluster Analysis of Yeast Genome-wide Expression Patterns Obtained by Treating With Different Antifungal Agents
ZHANG Liang,ZHANG Yan,ZHOU Yi-Ming,AN Shuang,GUO De-An,ZHOU Yu-Xiang,ZENG Ling-Wen and CHENG Jing.Cluster Analysis of Yeast Genome-wide Expression Patterns Obtained by Treating With Different Antifungal Agents[J].Progress In Biochemistry and Biophysics,2002,29(4):538-542.
Authors:ZHANG Liang  ZHANG Yan  ZHOU Yi-Ming  AN Shuang  GUO De-An  ZHOU Yu-Xiang  ZENG Ling-Wen and CHENG Jing
Institution:Department of Biological Sciences and Biotechnology, Tsinghua University;National Engineering Research Center for Beijing Biochip Technology;Department of Biological Sciences and Biotechnology, Tsinghua University;National Engineering Research Center for Beijing Biochip Technology;Department of Biological Sciences and Biotechnology, Tsinghua University;National Engineering Research Center for Beijing Biochip Technology;National Engineering Research Center for Beijing Biochip Technology;The State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Science, Peking University, Beijing 100083, China;Department of Biological Sciences and Biotechnology, Tsinghua University;The State Key Laboratory of Biomembrane and Membrane Biotechnology, Tsinghua University;National Engineering Research Center for Beijing Biochip Technology;National Engineering Research Center for Beijing Biochip Technology;Department of Biological Sciences and Biotechnology, Tsinghua University;The State Key Laboratory of Biomembrane and Membrane Biotechnology, Tsinghua University;National Engineering Research Center for Beijing Biochip Technology;Department of Pharmacology
Abstract:To examine the application of DNA microarray in drug discovery and development, cluster analysis for genome-wide expression data was tested after Saccharomyces cerevisiae was treated with nine antifungal agents with known and unknown pharmacological mechanisms. The results indicated that antifungal agents with similar action mode were clustered together. Amphotericin B and nystatin, ketoconazole and clotrimazole have been known to have similar antifungal mechanism respectively. Consistent with their known mechanisms, amphotericin B and nystatin were clustered together; also ketoconazole and clotrimazole were clustered together based on their expression patterns. Solasodine, which was known to inhibit the synthesis of ergosterol, had a close clustering position with ketoconazole and clotrimazole group. Analyzing the relationship among the known and unknown drugs using cluster approach, It can be infered that the pharmacological mechanisms of unknown drugs from their clustering positions relating to the known drugs.
Keywords:DNA microarray  cluster analysis  antifungal agents
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《生物化学与生物物理进展》浏览原始摘要信息
点击此处可从《生物化学与生物物理进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号